• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prolonged maintained remissions of adult acute non-lymphocytic leukaemia.

作者信息

Peterson B A, Bloomfield C D

出版信息

Lancet. 1977 Jul 23;2(8030):158-60. doi: 10.1016/s0140-6736(77)90178-7.

DOI:10.1016/s0140-6736(77)90178-7
PMID:69780
Abstract

Maintenance chemotherapy consisting of weekly oral 6-thioguanine and intramuscular cytosine arabinoside was administered to 24 adult patients with acute non-lymphocytic leukaemia in complete remission. The median duration of complete remission was 16-5 months, with 9 patients (38%) still in their first remission after 18--56 months. 33% of the patients have been in continuous remission for over 2 yr, 21% for over 3 yr, and 12-5% for over 4 yr. Median survival so far is 22-5 months. This maintenance regimen is well tolerated, is easily administered on an outpatient basis, and produces substantial numbers of long-term remissions.

摘要

相似文献

1
Prolonged maintained remissions of adult acute non-lymphocytic leukaemia.
Lancet. 1977 Jul 23;2(8030):158-60. doi: 10.1016/s0140-6736(77)90178-7.
2
The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.硫鸟嘌呤对柔红霉素、阿糖胞苷和泼尼松联合治疗成人急性白血病的疗效。芬兰白血病研究组。
Scand J Haematol. 1979 Aug;23(2):124-8.
3
High remission-induction rate in acute myeloid leukaemia.
Lancet. 1977 Mar 5;1(8010):497-9. doi: 10.1016/s0140-6736(77)91366-6.
4
Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.急性非淋巴细胞白血病的缓解期维持治疗:阿糖胞苷加6-硫鸟嘌呤与一系列化疗方案的比较
Cancer. 1980 Jul 1;46(1):22-8. doi: 10.1002/1097-0142(19800701)46:1<22::aid-cncr2820460104>3.0.co;2-p.
5
[Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
Bull Cancer. 1974 Jul-Sep;61(3):411-8.
6
Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
Recent Results Cancer Res. 1973;43:165-8.
7
Maintenance of remission in adult acute nonlymphoblastic leukemia using intermittent courses of cytosine arabinoside (NSC-63878) and 6-thioguanine (NSC-752).
Cancer Treat Rep. 1976 May;60(5):585-9.
8
A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
Biomedicine. 1973 May;18(3):192-8.
9
Cytosine arabinoside as a single agent in the therapy of adult acute leukemia.
Am J Med Sci. 1974 Sep;268(3):163-8. doi: 10.1097/00000441-197409000-00005.
10
Cytosine arabinoside and 6-thioguanine in refractory acute lymphocytic leukemia.
Cancer. 1974 Feb;33(2):539-44. doi: 10.1002/1097-0142(197402)33:2<539::aid-cncr2820330232>3.0.co;2-e.

引用本文的文献

1
Inching toward cure of acute myeloid leukemia: a summary of the progress made in the last 50 years.迈向急性髓系白血病治愈之路:过去50年进展总结
Med Oncol. 2014 Aug;31(8):136. doi: 10.1007/s12032-014-0136-z. Epub 2014 Jul 22.
2
Optimal therapy for adult patients with acute myeloid leukemia in first complete remission.成人急性髓细胞白血病完全缓解后患者的最佳治疗方法。
Curr Treat Options Oncol. 2014 Jun;15(2):171-86. doi: 10.1007/s11864-014-0281-9.
3
Update on optimal management of acute myeloid leukemia.急性髓系白血病的最佳治疗进展。
Clin Med Insights Oncol. 2013 Aug 12;7:181-97. doi: 10.4137/CMO.S8528. eCollection 2013.
4
A phase 1 dose-escalation study of ARRY-520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias.一项评估 ARRY-520(一种驱动蛋白纺锤体蛋白抑制剂)在晚期髓性白血病患者中的 1 期剂量递增研究。
Cancer. 2012 Jul 15;118(14):3556-64. doi: 10.1002/cncr.26664. Epub 2011 Dec 2.
5
Recurrence of acute myelogenous leukemia with the same AML1/ETO breakpoint as at diagnosis after complete remission lasting 15 years: analysis of stored bone marrow smears.急性髓系白血病完全缓解持续15年后复发,复发时的AML1/ETO断点与诊断时相同:对储存骨髓涂片的分析
Int J Hematol. 2003 Nov;78(4):362-9. doi: 10.1007/BF02983563.
6
Bone marrow transplantation in Canada.加拿大的骨髓移植
Can Med Assoc J. 1980 Jul 5;123(1):19-22.
7
[Changes of therapy results in acute leukemia under different treatment schedules with special reference to gnotobiotic measures].
Klin Wochenschr. 1983 Apr 1;61(7):329-38. doi: 10.1007/BF01485023.